Background Invasive coronary function testing (CFT) is indicated in patients with refractory angina with non-obstructed coronary arteries (ANOCA). Despite this, questions remain regarding patient ...

Background Delays in performing urgent coronary artery bypass graft (CABG) surgery are increasing across the UK, with ...

Introduction The clinical management of Obstructive Hypertrophic Cardiomyopathy remains challenging, and the phase III ...

Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk ...

Background Patients with heart failure (HF) and severe mitral regurgitation (MR) have poor outcomes. Early identification ...

Background The limited literature provides minimal information on clinical outcomes among patients undergoing percutaneous coronary intervention (PCI) under different healthcare funding systems, ...

Background Secondary prevention is critical for patients with established atherosclerotic cardiovascular diseases (ASCVD).

APCU25CR28 Navigating dual diagnosis: case report of amyloid transthyretin (ATTR) cardiac amyloidosis and amyloid light-chain (AL) (13 February, 2026) ...

Background Non-ST-segment-elevation myocardial infarction (NSTEMI) accounts for the majority of acute coronary syndrome presentations. Invasive coronary angiography (ICA) is recommended but ...

Aims Heart failure (HF) often coexists with chronic kidney disease (CKD), impacting prognosis. This study aims to evaluate renal function trajectories and their impact on major clinical outcomes in a ...

Introduction Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have revolutionized lipid management, particularly in patients with atherosclerotic cardiovascular disease (ASCVD) and ...

Introduction Athletes with neurological impairments such as cerebral palsy (CP) present unique challenges in cardiovascular screening. Usually, T-wave inversion in leads V1–V4 on an athlete’s ...